Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Inositol Caps 500mg 500 mg Capsule is a Health Canada–registered human drug (DIN 01984446) held by Twin Laboratories Inc., containing Inositol. Health Canada lists its status as Cancelled Post Market (status date 10 Nov 1999). Nexara Health has matched 13 registrations of Inositol across 3 other regulated markets.

Health Canada registration

DIN01984446
Brand nameInositol Caps 500mg
Active ingredientInositol
Strength500 mg
Dosage formCapsule
RouteOral
CompanyTwin Laboratories Inc.
StatusCancelled Post Market — 10 Nov 1999
ClassHuman
ATC
AHFS88:30.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Inositol registered in other markets

13 registrations of the same molecule in 3 national registries outside Canada (first 11 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
Dominican RepublicKal InositolNutraceutical CorporationRegisteredMISPAS
Dominican RepublicSolaray InositolNutraceutical CorporationRegisteredMISPAS
MalaysiaLuckyAngel2u INOSITOL 500MG CAPSULELuckyangel To UHealth SupplementPRODUCT APPROVEDNPRA
United StatesInositolNuray Chemicals Private LimitedPowderFDA NDC
United StatesInositolAX Pharmaceutical CorpPowderFDA NDC
United StatesInositolSthree Chemicals Private LimitedPowderFDA NDC
United StatesInositolSCH Global Services Private LimitedPowderFDA NDC
United StatesInositolCeyone Life Sciences Private LimitedPowderFDA NDC
United StatesInositolQingdao Qinzeyuan Biotechnology Co., LtdPowderFDA NDC
United StatesInositolQingdao Biopeptek Co., Ltd.PowderFDA NDC
United StatesInositolWillow Birch PharmaPowderFDA NDC

See every manufacturer of Inositol worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Inositol Caps 500mg (DIN 01984446) marketed in Canada?

No. Health Canada lists DIN 01984446 as Cancelled Post Market as of 10 Nov 1999.

Who holds the Canadian licence for this product?

Twin Laboratories Inc. is the company of record in the Health Canada Drug Product Database.

Is Inositol registered outside Canada?

Yes — Nexara Health has matched 13 registrations in 3 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 01984446, status date 1999-11-10; national medicine registries: FDA NDC, MISPAS, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 01984446, status date 1999-11-10; national medicine registries: FDA NDC, MISPAS, NPRA.

Health Canada Drug Product Database (DPD), DIN 01984446, status date 1999-11-10; national medicine registries: FDA NDC, MISPAS, NPRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.